Tyra Biosciences IPO

Tyra Biosciences targets resistance in oncology with purpose built drugs for the benefit of patients.

Register for Details

For more details on financing and valuation for Tyra Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Tyra Biosciences

Forge green plus iconForge green minus icon

What is Tyra Biosciences's IPO price?

Tyra Biosciences's IPO price is $12.75 as of 1/18/24.
Forge green plus iconForge green minus icon

What is Tyra Biosciences's funding to date?

Tyra Biosciences has raised $157.64MM to date.
Forge green plus iconForge green minus icon

When was Tyra Biosciences founded?

Tyra Biosciences was founded in 2018.

Tyra Biosciences Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
3/31/2021 Series B $106.3MM raised $XXX.XX $XXX.XX
1/10/2020 Series A $51.34MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Apr 19, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.